KYTX Stock Price History and Quote Analysis: Insights for Investors
Kyverna Therapeutics, Inc. Common Stock
Stock Price Today
Kyverna Therapeutics, Inc. Common Stock (KYTX) stock surged +4.63%, trading at $7.68 on NASDAQ, up from the previous close of $7.34. The stock opened at $7.33, fluctuating between $7.33 and $7.85 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Kyverna Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients suffering from autoimmune diseases. Its lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of patients with lupus nephritis and systemic sclerosis that is in Phase I clinical trial; and for myasthenia gravis and multiple sclerosis that is in Phase II clinical trial. The company is also developing KYV-201, an allogeneic CD19 CAR T-cell product candidate that is in preclinical stage to treat multiple autoimmune diseases. In addition, it is developing product candidates to treat other autoimmune diseases, such as inflammatory bowel disease that includes Crohn's disease and ulcerative colitis. Kyverna Therapeutics, Inc. has a license and collaboration agreement with Intellia Therapeutics, Inc. to research and develop an allogeneic CD19-directed CAR cell therapy product; and with Kite to research and develop programs for the treatment, diagnosis, and prevention of autoimmune, inflammatory, and allogeneic stem cell transplant inflammatory diseases. The company was formerly known as BAIT Therapeutics, Inc. and changed its name to Kyverna Therapeutics, Inc. in October 2019. Kyverna Therapeutics, Inc. was incorporated in 2018 and is headquartered in Emeryville, California.
Company Information
| Employees | 112 |
| Beta | 0 |
| Sales or Revenue | N/A |
| 5Y Sales Change% | -1% |
| Fiscal Year Ends | N/A |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Kyverna Therapeutics, Inc. Common Stock (NASDAQ: KYTX) stock price is $7.68 in the last trading session. During the trading session, KYTX stock reached the peak price of $7.85 while $7.33 was the lowest point it dropped to. The percentage change in KYTX stock occurred in the recent session was 4.63% while the dollar amount for the price change in KYTX stock was $0.34.
The NASDAQ listed KYTX is part of Biotechnology industry that operates in the broader Healthcare sector. Kyverna Therapeutics, Inc. Common Stock designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
No Data
KYTX's closing price is 16.51% higher than its 52-week low of $6.30 where as its distance from 52-week high of $30.60 is -76.01%.
Number of KYTX employees currently stands at 112.
Official Website of KYTX is: https://www.kyvernatx.com
KYTX could be contacted at phone 0 and can also be accessed through its website. KYTX operates from NaN, NaN, NaN, .
KYTX stock volume for the day was 58.47K shares. The average number of KYTX shares traded daily for last 3 months was 623.41K.
The market value of KYTX currently stands at $331.37M with its latest stock price at $7.68 and 43.15M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com